Skip to content

SILO PHARMA, INC.: 10-Q filed 2022-08-01

What SILO PHARMA, INC. reported in its quarterly report filed 2022-08-01 (fiscal Q2 2022): 33 published measures, 96 facts as tagged in accession 0001213900-22-043390.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-01
Fiscal period
fiscal Q2 2022
Accession
0001213900-22-043390 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SILO PHARMA, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-309,044,715USD
At 2021-12-3110,490,189USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-301,170,678USD
At 2021-12-311,427,923USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-307,874,037USD
At 2022-03-318,503,203USD
At 2021-12-319,062,266USD
At 2021-06-303,765,833USD
At 2021-03-314,227,823USD
At 2020-12-311,280,695USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-06-308,734,434USD
At 2021-12-319,837,001USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-658,402USD91
2022-01-01 to 2022-06-30-1,262,474USD181
2021-04-01 to 2021-06-30-461,990USD91
2021-01-01 to 2021-06-30-1,392,692USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-1,189,274USD181
2021-01-01 to 2021-06-30-841,063USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-06-303,794,102USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-06-3086,707USD181
2021-01-01 to 2021-06-3069,500USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-4,525,051USD
At 2021-12-31-3,262,577USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-04-01 to 2022-06-3099,395,304shares91
2022-01-01 to 2022-06-3099,018,232shares181
2021-04-01 to 2021-06-3096,857,408shares91
2021-01-01 to 2021-06-3091,032,045shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.01USD/shares91
2022-01-01 to 2022-06-30-0.01USD/shares181
2021-04-01 to 2021-06-300USD/shares91
2021-01-01 to 2021-06-30-0.03USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-01-01 to 2022-06-300USD/shares181
2021-04-01 to 2021-06-300USD/shares91
2021-01-01 to 2021-06-300USD/shares181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-04-01 to 2022-06-30100,212USD91
2022-01-01 to 2022-06-30227,393USD181
2021-04-01 to 2021-06-3054,942USD91
2021-01-01 to 2021-06-30167,234USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-494,285USD91
2022-01-01 to 2022-06-30-1,021,544USD181
2021-04-01 to 2021-06-30-436,849USD91
2021-01-01 to 2021-06-30-1,337,985USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-06-308,947,385USD
At 2021-12-3110,402,320USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-06-30268,845USD
At 2021-12-31490,039USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-30510,851USD91
2022-01-01 to 2022-06-301,054,676USD181
2021-04-01 to 2021-06-30453,415USD91
2021-01-01 to 2021-06-301,371,113USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-3058,447USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-3016,566USD91
2022-01-01 to 2022-06-3033,132USD181
2021-04-01 to 2021-06-3016,566USD91
2021-01-01 to 2021-06-3033,128USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-04-01 to 2022-06-301,459USD91
2022-01-01 to 2022-06-302,919USD181
2021-04-01 to 2021-06-301,460USD91
2021-01-01 to 2021-06-302,085USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2022-04-01 to 2022-06-3025,918USD91
2022-01-01 to 2022-06-3062,743USD181
2021-04-01 to 2021-06-3045,706USD91
2021-01-01 to 2021-06-30116,735USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-04-01 to 2022-06-30105,676USD91
2022-01-01 to 2022-06-30275,955USD181
2021-01-01 to 2021-12-31147,448USD365
2021-04-01 to 2021-06-3098,846USD91
2021-01-01 to 2021-06-30147,448USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-3099,395,304shares
At 2021-12-3198,636,970shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-06-308,734,434USD
At 2021-12-319,837,001USD
At 2021-06-304,150,928USD
At 2020-12-311,128,389USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-06-3012,389,148USD
At 2021-12-3112,314,979USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-06-3063,590USD
At 2021-12-3161,210USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-06-3099,939USD
At 2021-12-31145,324USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-658,402USD91
2022-01-01 to 2022-06-30-1,261,311USD181
2021-04-01 to 2021-06-30-388,807USD91
2021-01-01 to 2021-06-30-1,252,542USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-658,402USD91
2022-01-01 to 2022-03-31-604,072USD90
2021-04-01 to 2021-06-30-461,990USD91
2021-01-01 to 2021-03-31-930,702USD90

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-283USD91
2022-01-01 to 2022-06-30-283USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-164,117USD91
2022-01-01 to 2022-06-30-239,767USD181
2021-04-01 to 2021-06-3048,042USD91
2021-01-01 to 2021-06-3085,443USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-06-30224USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2022-01-01 to 2022-06-3025,159USD181

Inspect the source

Entity
SILO PHARMA, INC. / CIK 0001514183
Captured
2026-09-20T09:13:20.337Z
SEC response SHA-256
b55b01ff5b31c52a933a54029f5fe837eae02333bd43de16acad37f51e3b67db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001514183.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))